MedPath

PLUS PINK: HHRP+ Adaptation for Women With HIV Under Community Supervision

Not Applicable
Completed
Conditions
HIV
Interventions
Behavioral: Holistic Health Recovery Program for HIV+
Registration Number
NCT03175094
Lead Sponsor
Yale University
Brief Summary

After enrollment, participants will be randomized to either receive the intervention (treatment) from trained health educators or undergo observation as usual (control group). Randomization will be stratified by HIV serostatus. A control group is appropriate because participants will still receive services offered through probation and will be offered the intervention after completion of the trial. Subjects will be paid, not for participating in the intervention, but for providing research assessments. The newly adapted intervention will be delivered over no more than a 3-month period (it will be shorter if the adaptation process is supportive). Baseline assessments will assess the pre-intervention period. The 3-month assessment will be the end-of-intervention effects and the post-intervention assessments will be at 6, 9 and 12 months. HIV prevention knowledge will be assessed based on quizzes used previously for HHRP+; though final quiz content will depend on final selected materials for the intervention. Subjects will be followed for 12 months with assessments by trained research assistants.

Detailed Description

The aim of this study is to adapt and pilot test the Holistic Health Recovery Program for women with and at risk for HIV (HHRP+), a CDC evidence-based secondary HIV prevention intervention, that will serve as a framework to optimize HIV treatment outcomes and reduce HIV-associated risk for women under correctional community supervision.

Hypotheses

1. It will be feasible to recruit and retain HIV+ and at-risk women under community correctional supervision in the pilot study.

2. Using the ADAPT-ITT methods, we will be able to adequately adapt HHRP+ for HIV-infected and at-risk women under community supervision.

3. The adapted intervention will be feasible to implement and acceptable to participants.

4. The adapted intervention will produce higher measureable preliminary effects on HIV-focused treatment outcomes in the intervention group compared with the control group.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • age ≥18 years old
  • female
  • have laboratory confirmed HIV OR are at-risk for HIV (ever injected drugs, ever engaged in commercial sex work, were incarcerated in prison or jail within the past 2 years, had condomless sex with an HIV+ partner or partner whose HIV status is unknown in the past 90 days, or had a diagnosed sexually transmitted infection in the past 90 days),
  • and are under or anticipating transfer to probation.are either a) sentenced to probation or on intensive pretrial supervision by a probation officer; b) sentenced to parole; or c) incarcerated in jail or prison in the prior 60 days.

Potential participants will be excluded

Read More
Exclusion Criteria
  • unable or unwilling to provide informed consent,
  • have <3 months of remaining scheduled supervision term,
  • or are threatening to staff
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Holistic Health Recovery Program for HIV+ InterventionHolistic Health Recovery Program for HIV+-
Primary Outcome Measures
NameTimeMethod
Change in HIV knowledge from baseline3 months

HIV knowledge quiz with scores ranging from 0-100, a higher score indicating better knowledge

Secondary Outcome Measures
NameTimeMethod
Change in Sex-related risk behaviors over timebaseline, 6 months, 12 months

NIDA Risk Behavior Assessment (0-18 with higher scores indicating higher risk)

Change in Injection-related risk behaviors over timebaseline, 6 months, 12 months

NIDA Risk Behavior Assessment (0-18 with higher scores indicating higher risk)

Trial Locations

Locations (1)

Yale AIDS Program

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath